MetLife Investment Management LLC Buys 4,219 Shares of Maximus, Inc. (NYSE:MMS)

MetLife Investment Management LLC boosted its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 6.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 68,689 shares of the health services provider's stock after buying an additional 4,219 shares during the period. MetLife Investment Management LLC owned approximately 0.12% of Maximus worth $5,128,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Nordea Investment Management AB acquired a new stake in Maximus in the 4th quarter worth $4,618,000. Fort Washington Investment Advisors Inc. OH grew its position in Maximus by 39.1% during the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider's stock worth $22,132,000 after buying an additional 83,390 shares in the last quarter. IFP Advisors Inc increased its stake in Maximus by 62.4% during the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after acquiring an additional 302 shares during the period. Mirae Asset Global Investments Co. Ltd. bought a new position in Maximus during the fourth quarter valued at about $1,113,000. Finally, Legato Capital Management LLC raised its holdings in Maximus by 33.9% in the 4th quarter. Legato Capital Management LLC now owns 32,134 shares of the health services provider's stock valued at $2,399,000 after acquiring an additional 8,138 shares in the last quarter. Institutional investors own 97.21% of the company's stock.

Maximus Price Performance

NYSE:MMS traded down $0.91 during mid-day trading on Tuesday, hitting $66.62. The company's stock had a trading volume of 31,235 shares, compared to its average volume of 551,781. The company has a market capitalization of $3.77 billion, a price-to-earnings ratio of 14.37 and a beta of 0.68. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.97. The stock has a fifty day moving average of $67.63 and a 200-day moving average of $74.24.

Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. As a group, equities analysts forecast that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.80%. Maximus's payout ratio is presently 25.81%.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the company. StockNews.com cut Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th. Raymond James raised shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target on the stock in a report on Thursday, January 2nd.

Insider Activity

In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of the business's stock in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the transaction, the insider now directly owns 2,512 shares in the company, valued at $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Jan Madsen sold 2,439 shares of the company's stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the sale, the director now directly owns 18,097 shares in the company, valued at $1,225,347.87. This represents a 11.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.